Legend Biotech (LEGN) Interest Expenses (2019 - 2025)
Legend Biotech (LEGN) posted Interest Expenses of -$5.5 million for Q4 2025, up 2.41% on a QoQ basis from -$5.6 million in Q3 2025, and down 5.77% year-over-year from -$5.8 million in Q4 2024.
Legend Biotech (LEGN) has 7 years of Interest Expenses data on file, last reported at -$5.5 million in Q4 2025.
- In Q4 2025, Interest Expenses fell 5.77% year-over-year to -$5.5 million; the TTM figure through Dec 2025 stood at -$21.4 million (down 99.93% YoY), while the FY2025 annual figure was -$21.4 million, up 0.93% from the prior year.
- Interest Expenses climbed to -$5.5 million in Q4 2025, from -$5.6 million in the prior quarter.
- Across five years, Interest Expenses topped out at $5.5 million in Q1 2024 and bottomed at -$5.7 million in Q3 2023.
- A 5-year average of -$2.5 million and a median of -$4.1 million in 2022 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2023 — Interest Expenses surged 589.75% — and 2024, when it plunged 89247.08%.
- Year by year, Interest Expenses stood at -$602000.0 in 2021, then slumped by 707.48% to -$4.9 million in 2022, then soared by 99.88% to -$5820.0 in 2023, then plunged by 89247.08% to -$5.2 million in 2024, then decreased by 5.77% to -$5.5 million in 2025.
- The last three Interest Expenses figures came in at -$5.5 million (Q4 2025), -$5.6 million (Q3 2025), and -$5.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 12.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.50 Mn |
| Dec 31, 2025 | -5.50 Mn |
| Sep 30, 2025 | -5.64 Mn |
| Sep 30, 2025 | -5.64 Mn |
| Jun 30, 2025 | -5.22 Mn |
| Jun 30, 2025 | -5.22 Mn |
| Mar 31, 2025 | 5.06 Mn |
| Mar 31, 2025 | 5.06 Mn |
| Dec 31, 2024 | -5.20 Mn |
| Dec 31, 2024 | -5.20 Mn |
| Sep 30, 2024 | -5.50 Mn |
| Sep 30, 2024 | -5.50 Mn |
| Jun 30, 2024 | -5.48 Mn |
| Jun 30, 2024 | -5.48 Mn |
| Mar 31, 2024 | -5.48 Mn |
| Mar 31, 2024 | -5.48 Mn |
| Dec 31, 2023 | -5,820.00 |
| Dec 31, 2023 | -5,820.00 |
| Sep 30, 2023 | -5.68 Mn |
| Sep 30, 2023 | -5.68 Mn |
| Jun 30, 2023 | -5.19 Mn |
| Jun 30, 2023 | -5.19 Mn |
| Mar 31, 2023 | -5.11 Mn |
| Mar 31, 2023 | -5.11 Mn |
| Dec 31, 2022 | -4.86 Mn |
| Dec 31, 2022 | -4.86 Mn |
| Sep 30, 2022 | -3.25 Mn |
| Sep 30, 2022 | -3.25 Mn |
| Jun 30, 2022 | -1.64 Mn |
| Jun 30, 2022 | -1.64 Mn |
| Mar 31, 2022 | -1.04 Mn |
| Mar 31, 2022 | -1.04 Mn |
| Dec 31, 2021 | -602,000.00 |
| Dec 31, 2021 | -602,000.00 |
| Sep 30, 2021 | -208,000.00 |
| Sep 30, 2021 | -208,000.00 |
| Jun 30, 2021 | -52,000.00 |
| Jun 30, 2021 | -52,000.00 |
| Mar 31, 2021 | 38,000.00 |
| Mar 31, 2021 | 38,000.00 |
| Dec 31, 2020 | -40,000.00 |
| Dec 31, 2020 | -40,000.00 |
| Sep 30, 2020 | -90,000.00 |
| Sep 30, 2020 | -90,000.00 |
| Jun 30, 2020 | -88,000.00 |
| Jun 30, 2020 | -88,000.00 |
| Mar 31, 2020 | -3.99 Mn |
| Mar 31, 2020 | -3.99 Mn |
| Dec 31, 2019 | -84,000.00 |
| Dec 31, 2019 | -84,000.00 |
| Sep 30, 2019 | -82,000.00 |
| Sep 30, 2019 | -82,000.00 |
| Jun 30, 2019 | -19,000.00 |
| Jun 30, 2019 | -19,000.00 |